Board Changes
Updated : 14:54
29 November 2024
IRONVELD PLC
Board Changes
Ironveld PLC ("Ironveld" or the "Company"), the owner of a High Purity Iron ("HPI"), Vanadium, and Titanium project (the "Project"), located on the Northern Limb of the Bushveld Complex in Limpopo Province, South Africa, announces that Giles Clarke has informed the Company that he has taken the decision to retire from the Board and as a Non-Executive Director of Ironveld, with immediate effect.
In May 2024, Kristoffer Andersson was appointed as Chief Executive Officer of Ironveld and since this time has worked alongside Dr John Wardle, Executive Chairman, to identify key operational objectives and establish a strategy that would enable the Company to realise the value from the Project. As a result of the successful placing and subscription to raise £2.5 million, which completed in November 2024, the Company is now well placed to implement this strategy, and the Board looks forward to updating shareholders on progress in the coming months.
Following Giles Clarke's resignation and completion of the capital raise, John Wardle has assumed the role of Non-Executive Chairman of the Company.
John Wardle, Non-Executive Chairman, commented: "Giles has served on the Board of Ironveld since 2010 and I would like to thank him for the support and insight he has provided to the Company during this time. The Board wish Giles all the best for the future, and we now focus on a period when we expect to see transformation progress at the Project, including increased production, and the commencement of revenues and positive cash flow."
For further information, please contact:
Ironveld plc Kristoffer Andersson, Chief Executive Officer | c/o BlytheRay +44 20 7138 3204
| |
Cavendish Capital Markets Limited (Nomad and Broker) Derrick Lee / Adam Rae | +44 20 7220 0500 | |
Turner Pope Investments (TPI) Ltd (Joint Broker) Andrew Thacker / James Pope | +44 20 3657 0050 | |
BlytheRay Tim Blythe / Megan Ray | +44 20 7138 3204 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.